Your browser doesn't support javascript.
loading
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Beldi-Ferchiou, Asma; Jais, Jean-Philippe; Ghesquieres, Hervé; Casasnovas, Rene Olivier; Tilly, Hervé; Fruchart, Christophe; Morschhauser, Franck; Haioun, Corinne; Lazarovici, Julien; Perrot, Aurore; Nicolas-Virelizier, Emmanuelle; Salles, Gilles; Godard, Nathalie; Zamali, Imen; De Colella, Jean-Marc Schiano; Claudel, Alexis; Corront, Bernadette; Oberic, Lucie; Briere, Josette; Gaulard, Philippe; Thieblemont, Catherine; Delfau-Larue, Marie-Hélène.
Afiliación
  • Beldi-Ferchiou A; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France.
  • Jais JP; Biostatistics Unit, APHP, Univ Paris Descartes, Paris, France.
  • Ghesquieres H; Hematology, Centre Hospitalier Lyon Sud, PIERRE-BENITE, Lyon, France.
  • Casasnovas RO; Hematology, CHU Dijon Bourgogne and INSERM U 1231, Dijon, France.
  • Tilly H; INSERM U918, Centre Henri Becquerel, Rouen, France.
  • Fruchart C; Institut d'Hématologie de Basse Normandie, CHU Caen, Caen, France.
  • Morschhauser F; Clinical Hematology, Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.
  • Haioun C; Lymphoid Malignancies Unit, APHP, Hopital Henri Mondor, Creteil, France.
  • Lazarovici J; Clinical Hematology, Gustave Roussy Cancer Center, Villejuif, France.
  • Perrot A; Hematology department, CHU Brabois, Vandoeuvre les Nancy, France.
  • Nicolas-Virelizier E; Onco Hematology, Centre Leon Berard, Lyon, France.
  • Salles G; Hematology, Centre Hospitalier Lyon Sud, PIERRE-BENITE, Lyon, France.
  • Godard N; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France.
  • Zamali I; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France.
  • De Colella JS; Onco Hematology, Institut Paoli Calmettes, Marseille, France.
  • Claudel A; Biological Hematology and Immunology department, APHP, INSERM U 955, Hopital Henri Mondor, Creteil, France.
  • Corront B; Hematology, CH Annecy Genevois, Epagny Metz-Tessy, France.
  • Oberic L; Hematology, IUC - Oncopole CHU Toulouse, Toulouse, France.
  • Briere J; Pathology, APHP, Hopital Saint-Louis, Paris, France.
  • Gaulard P; AP-HP, Henri Mondor Hospital, Pathology Department, Créteil, France.
  • Thieblemont C; Univ Paris Est Créteil, INSERM, IMRB, Créteil, France.
  • Delfau-Larue MH; Assistante publique - Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, DMU DHI, Université de Paris, Paris, France.
Br J Haematol ; 201(2): 256-266, 2023 04.
Article en En | MEDLINE | ID: mdl-36740991
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Recurrencia Local de Neoplasia Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido